FOCUS Promo - Program airs May 2nd
Did you ever wonder what it really takes to become a doctor? The FOCUS Team takes you inside the Temple St. Luke #39;s Medical School and shows you a day in the life of a med student. Then, for...
By: PBS39
Read more from the original source:
Where Do We Go Next with EGFR Inhibitors?
Dr. Geoffrey Oxnard from Harvard Medical School talks about EGFR inhibitors and mutations, filmed at IASLC in February 2014. Oncology.TV would like to acknowledge CancerGrace.org and the Lungevity...
By: Oncology.TV
Here is the original post:
Update on ECOG 1505 Trial
Dr. Heather Wakelee from Stanford University Medical School talks about ECOG 1505, filmed at IASLC in February 2014. Oncology.TV would like to acknowledge CancerGrace.org and the Lungevity...
By: Oncology.TV
Read this article:
How Do You Help Your EGFR Patients Make Treatment Decisions When Their Cancers Grow?
Dr. Geoffrey Oxnard from Harvard Medical School talks about EGFR treatment decisions, filmed at IASLC in February 2014. Oncology.TV would like to acknowledge CancerGrace.org and the Lungevity...
By: Oncology.TV
Link:
How Do You Help Your EGFR Patients Make Treatment Decisions When Their Cancers Grow? - Video
Will Erlotinib Prevent Disease Recurrence in Patients with Early Stage EGFR Positive NSCLC?
Dr. Joel Neal from Stanford University Medical School talks about erlotinib, filmed at IASLC in February 2014. Oncology.TV would like to acknowledge CancerGrace.org and the Lungevity Foundation...
By: Oncology.TV
Read more:
Will Erlotinib Prevent Disease Recurrence in Patients with Early Stage EGFR Positive NSCLC? - Video
What #39;s the Status and Potential Utility of Cabozantinib in Lung Cancer?
Dr. Heather Wakelee from Stanford University Medical School talks about the status and potential utility of cabozantinib in lung cancer, filmed at IASLC in February 2014. Oncology.TV would...
By: Oncology.TV
Go here to read the rest:
What's the Status and Potential Utility of Cabozantinib in Lung Cancer? - Video
Molecular Testing for Early Stage Lung Cancer Patients - Is it Necessary?
Dr. Joel Neal from Stanford University Medical School talks about molecular testing, filmed at IASLC in February 2014. Oncology.TV would like to acknowledge CancerGrace.org and the Lungevity...
By: Oncology.TV
See original here:
Molecular Testing for Early Stage Lung Cancer Patients - Is it Necessary? - Video
Medical School Fever
What if some of UNC #39;s faculty attended medical school at the same time in the 1970 #39;s and were preparing for the first skit night in the history of the School of Medicine? UNC School of Medicine...
By: Matt Krantz
More here:
Physician Focus: Oral Health
http://www.massmed.org/physicianfocus | Dr. Silk, Chair of the Massachusetts Medical Society #39;s Committee on Oral Health and a Clinical Associate Professor at the University of Massachusetts Medical...
By: MassMedicalSociety
More here:
The Mitochondrial Theory of Aging-Professor David Sinclair
The Role of Mitochondria in Aging and Diseases - David Sinclair, Professor, Department of Genetics, Harvard Medical School.
By: Dapo Orukotan
Read more:
The Mitochondrial Theory of Aging-Professor David Sinclair - Video
2014 JAMP TMDSAS Application Video
JAMP Students applying to Medical School EY2015.
By: TexasJAMP
Link:
PUBLIC RELEASE DATE:
30-Apr-2014
Contact: Bonnie Prescott bprescot@bidmc.harvard.edu 617-667-7306 Beth Israel Deaconess Medical Center
BOSTON Martin R. Pollak, MD, Chief of Nephrology at Beth Israel Deaconess Medical Center (BIDMC) and Professor of Medicine at Harvard Medical School, is among 84 new members and 21 foreign associates elected to the National Academy of Sciences (NAS). NAS fellows are chosen for distinguished and continuing achievements in original research.
The NAS is a private, nonprofit institution that was established under a congressional charter signed by President Lincoln in 1863. The academy recognizes achievement in science through election to its membership, and it also provides science, engineering and health policy advice to the federal government and other organizations. Scientists are elected by their peers to membership, and as the role of science has expanded in the United States, the National Academy has grown to include the Institute of Medicine, the National Academy of Engineering and the National Research Council.
Pollak joins BIDMC's Richard Sidman, MD, as an NAS member. BIDMC faculty members Jeffrey S. Flier, MD, Jerome E. Groopman, MD, Barbara B. Kahn, MD, Clifford B. Saper, MD, PhD, and Sharon K. Inouye, MD, MPH, are elected members of the Institute of Medicine.
Pollak's research has identified the genes involved in the development of focal segmental glomerulosclerosis (FSGS), a common form of renal injury which disproportionately strikes African Americans. His work has shown that two common coding sequence variants in the APOL1 gene confer both resistance to trypanosome b. rhodiesiense infection (an African sleeping sickness agent) and a seven-to-ten-fold increased susceptibility to FSGS and hypertension-associated kidney disease.
"Of the half a million people in the U.S. with kidney disease, one in three are African American," says Mark Zeidel, MD, PhD, Chairman of Medicine at BIDMC. "Martin Pollak's discovery that the APOL1 gene confers this risk helps us in our efforts to address and, hopefully, eliminate this disease disparity."
"Martin Pollak's investigations into the genetics and biology of this widespread disease hold great promise for the field of nephrology," adds BIDMC Chief Academic Officer Vikas P. Sukhatme, MD, PhD. "The next key step will be to identify the mechanisms by which mutations in the APOL1 gene lead to a greater propensity for kidney damage. This innovative research is a tremendous example of how laboratory discoveries reach our patients, and could help clinicians to better tailor treatments to specific forms of kidney disease. Dr. Pollak's election to the NAS is a reflection of this critically important work."
###
See more here:
BIDMC's Martin Pollak, M.D., elected to National Academy of Sciences
How "Hide and Play Dead" Makes Headlines: PART THREE, CONTINUED
The nature of educational elitism, thwarted by my parents #39; plots against my uniqueness, and my inside story of the medical field in the late 70 #39;s and early 80 #39;s, is riveting and naturally raises...
By: Michael King
Go here to read the rest:
How "Hide and Play Dead" Makes Headlines: PART THREE, CONTINUED - Video
Is It Possible to Test Lung Tumors Without Doing a Biopsy?
Dr. Geoffrey Oxnard from Harvard Medical School talks about lung tumor biopsies, filmed at IASLC in February 2014. Oncology.TV would like to acknowledge CancerGrace.org and the Lungevity Foundatio...
By: Oncology.TV
More here:
Is It Possible to Test Lung Tumors Without Doing a Biopsy? - Video
Digital Health the Great Communicator Facilitating Precision Medicine
Visit: http://www.uctv.tv/) Dr. Aenor Sawyer plays a leadership role in digital health innovation where technology and health interface to facilitate precision medicine. Series: "UCSF Osher...
By: University of California Television (UCTV)
Read more here:
Digital Health the Great Communicator Facilitating Precision Medicine - Video
Targeted Treatment for Lung Cancer After Progression
Dr. Geoffrey Oxnard from Harvard Medical School talks about driver mutation, filmed at IASLC in February 2014. Oncology.TV would like to acknowledge CancerGrace.org and the Lungevity Foundation...
By: Oncology.TV
Read more:
Targeted Treatment for Lung Cancer After Progression - Video
Texas State Senator Kirk Watson Discusses the Medical School Initiative
By: TexasPoliticsProject .
Read more:
Texas State Senator Kirk Watson Discusses the Medical School Initiative - Video
The Herald-Dispatch
Dr. Joseph I. Shapiro, dean of the Marshall University Joan C. Edwards School of Medicine
Apr. 30, 2014 @ 12:00 AM
HUNTINGTON -- Marshall University and its medical school are offering up to 10 qualified West Virginia students annually a chance to complete requirements for becoming a doctor in a shorter time frame and potentially save tens of thousands of dollars in tuition.
The accelerated program announced Tuesday by Dr. Joseph Shapiro, dean of the Joan C. Edwards School of Medicine, means a student could complete a bachelor's degree and a doctor of medicine degree in seven years instead of the traditional eight.
In addition, a student who completes the undergraduate requirements of the program also would receive a waiver of tuition for all four years of medical school, officials said. At the school's current tuition rate, that would be a savings of more than $80,000 for a student.
The program, which will begin in the fall 2015 semester, is part of Marshall's efforts to develop a physician workforce for the region and increase in-state recruitment, Shapiro said in a news release.
"One of the ways we can facilitate that goal is to create programs that attract our state's best and brightest," he said. "This accelerated program allows us to place those highly performing students on a fast track to medical education."
Only 10 students annually will be accepted into the accelerated program, said Jennifer T. Plymale, associate dean for admissions at the school of medicine. She said the medical school will accept 75 students into the entire medical school class, and the accelerated program students will account for 10 of those spots.
Students who successfully complete the undergraduate requirements of the program will receive the tuition waiver for all four years of medical school, as well as a waiver from taking the MCAT, the entrance exam for medical school.
View post:
April 30, 2014, 4 a.m.
A MEDICAL school for Orange, higher student fees and funding for for-profit higher education providers - all is on the table for education in the 2014 federal budget.
A MEDICAL school for Orange, higher student fees and funding for for-profit higher education providers - all is on the table for education in the 2014 federal budget.
Treasurer Joe Hockey is expected to release the budget on Tuesday, May 13 and Charles Sturt University vice-chancellor Professor Andrew Vann is hopeful $45 million is set aside for a medical school.
Prior to last year's federal election, the National Party formally backed the university's planned Murray Darling Medical School, to be established over the Wagga Wagga and Orange campuses and in Ballarat.
"We're still leaning on the government and lobbying the government in relation to that," Professor Vann said.
"But everything we're hearing is about the lack of money available."
Professor Vann said the federal health department had been in "lengthy" discussions with CSU and he believed the department was aware of the "extremely good value" the medical school posed. Professor Vann said he was cautious about the rhetoric coming from Education Minister Christopher Pyne about proposed changes to the education sector, such as higher student fees and funding for for-profit universities.
Mr Pyne is considering the findings in the Kemp-Norton review, which promotes demand-driven funding where any private, non-university educator could be funded.
Professor Vann said the review highlighted a move to uncap the number of Commonwealth-funded places at public universities, allowing a focus on market demand.
See the original post here:
Opening a medical school has made itespecially important that Central Michigan University returns its human research protection program to compliance with federal regulations.
Provost Michael Gealt said the potential risks that come with research done by the College of Medicine amplify CMUs need to update its human research protection program.
Im looking, especially with the medical school, to make sure we get all the problems solved now before they really start increasing their research, Gealt said. We dont want to mess with those problems where (we) potentially could be working with human (research) that could actually be life threatening.
CMU discovered its non-compliance of university and federal regulations througha June 2013 external report done by HRP Consulting Inc., a New York-based firmthat focuses on improvingresearch policies.
Changes are not necessarily being made because of the College of Medicine, but because CMU has taken a look at its overall program and will be dedicating its time and resources to the improvement of the program, the report summarized.
The firmfound CMU lacks resources needed to have an effective humanresearch protection program, including staff, documentation, procedures, training and education.
It also found the university didnt have a university-wide process for dealing with HIPAA, Health Insurance Portability and Accountability Act, allowing for possible violations when dealing with student medical records during research.
The use of medical records for research purposes will only increase with the addition of the medical school, according to the report. Violations of HIPAA place the institution at significant regulatory and financial risk.
HIPAA protects U.S. citizens medical records and ensures they arent excluded from insurance coverage based on health-status related factors.
At least two CMED faculty members have experienced significant delays in their research due to review board backups, said Ed McKee, chairman of foundational sciences and a biochemistry professor.
Original post:
CMED creates necessity for improved human research protection program